Medicine and Dentistry
Urine Incontinence
100%
Enuresis
100%
Botulinum Toxin A
100%
Parasympatholytic
100%
Oral
30%
Placebo
20%
Quality of Life
20%
Urinary Tract Infection
20%
Xerostomia
20%
Primary Outcome
20%
Adverse Event
10%
Randomized Controlled Trial
10%
Urinary Retention
10%
Lanoteplase
10%
Solifenacin
10%
Table Salt
10%
Pharmacology, Toxicology and Pharmaceutical Science
Urine Incontinence
100%
Botulinum Toxin A
100%
Cholinergic Receptor Blocking Agent
100%
Enuresis
100%
Placebo
20%
Urinary Tract Infection
20%
Xerostomia
20%
Adverse Event
10%
Randomized Controlled Trial
10%
Urine Retention
10%
Lanoteplase
10%
Solifenacin
10%
Table Salt
10%
Keyphrases
Urgency Urinary Incontinence
100%
OnabotulinumtoxinA
100%
Complete Resolution
30%
Urinary Tract Infection
20%
Catheter
20%
Dry Mouth
20%
Oral Anticholinergic
20%
Intradetrusor Injection
20%
Placebo
10%
Adverse Events
10%
Low Dose Rate
10%
Quality of Life
10%
Mean Reduction
10%
In(III)
10%
Placebo-controlled Randomized Trial
10%
Outcome Analysis
10%
Between-group Difference
10%
Diary
10%
Urinary Retention
10%
Therapy Types
10%
Trospium
10%
Solifenacin
10%
3-day Diary
10%
Incontinence Quality of Life
10%